Lupus Research Alliance Novel Research Grants
Funds lupus-related translational research with innovation tracks designed for public health and industry collaboration.
The Lupus Research Alliance uses this funding line to back lupus research that can move diagnostics and treatments closer to clinic. The alliance is a U.S. 501(c)(3) that has awarded more than $284 million across more than 675 grants, and this route reflects that scale with a global reach for investigators working on the disease. Its mission is centered on next-generation diagnostics and curative treatments for people living with lupus. Across the named opportunities, support runs from $100,000 to $1 million, with a median award of $250,000 and an annual cadence. The strongest projects are for-profit, not nonprofit or individual, and sit around TRL 2 through 5 in lupus or autoimmune disease. The route covers the Global Team Science Award, Mechanistic Clinical Award, Translational Bridge Award, Lupus Innovation Award, the immune-resetting partnership with Genentech, and related research partnerships, so the funding menu is broad but still tightly disease-focused. Applicants do best when they bring a clear lupus question, a path to diagnosis or therapy, and enough translational depth to justify milestone-based support. The alliance’s broader platform also includes engineered cell therapy, career development, and other collaborative mechanisms, which shows a strong preference for work that can move from mechanism into patient impact. This is a strong fit for teams that can pair novelty with a direct line of sight to the clinic.
No upcoming rounds verified. Cadence: Annual.